Massachusetts General Hospital

Neurotherapeutics

We provide world class expertise to support industry and research collaborators in developing clinical trials to discover next generation neurotherapeutics. Our patients receive best in class facilities, resources, and treatments.
Drawing of a cross-section of a brain with different parts of the brain highlighted.
Drawing of a cross-section of a brain with different parts of the brain highlighted.

The Neurotherapeutics Hub

Uniquely placed at the center of the world’s largest concentration of biotechnology and research centers, Mass General neurotherapeutics programs aim to transform patient care through research and industry partnerships.

Industry Partnership

Mass General Neurotherapeutics designs, supports, and manages innovative observational and interventional trials for brain and psychiatric disorders.

Focusing on Patients to Find Cures

Our approach combines the highest level of patient care with experts using neurotherapeutic treatments in multi-disciplinary clinical departments.

Research and Clinical Programs

Experts across Mass General Neuroscience develop and implement neurotherapeutics and associated diagnostics for individuals with complex brain disorders.

Recent Advances in Neurotherapeutics

Read the latest research from our programs and laboratories from Mass General Neuroscience.

Mass General's neurotherapeutic development research program is situated among one of the world’s largest neuroscience, clinical and biotech communities.

2,000 + Researchers

Unparalleled Research Capabilities

We push scientific boundaries by training the best minds in the world

500+ Biotech Companies

Massachusetts Biotech Ecosystem

Worlds largest concentration of biotechnology and research centers.

1,200 + CLINICAL TRIALS

Mass General has 1,200 clinical trials taking place at any given time.

Support Mass General Neurotherapeutics

Massachusetts General Hospital Neuroscience clinical trials seeks to prevent and treat brain based diseases while advancing the development of novel therapies.